DNA SCRIPT INC

DNA SCRIPT INC specializes in the design and manufacturing of advanced DNA synthesis instruments and associated laboratory automation systems, with a focus on deoxyribonucleic acid (DNA) synthesizers and high-precision analytical instrumentation. Their technical expertise lies in microfluidic engineering, oligonucleotide synthesis platforms, and integrated software systems for genomic research applications. The company delivers end-to-end solutions that combine hardware instrumentation with custom software interfaces, enabling high-throughput, error-corrected DNA synthesis for research and defense applications. A key differentiator is their proprietary SYNTAX SYSTEM technology, which supports scalable, benchtop-scale nucleic acid manufacturing with industrial-grade reliability and reproducibility, positioning them as a niche provider in synthetic biology infrastructure. DNA SCRIPT INC has established a track record of serving the Department of Defense and the Department of Health and Human Services. For the DoD, they provide mission-critical DNA synthesis platforms used in biodefense, medical countermeasure development, and genomic surveillance programs. For HHS, they supply analytical laboratory instruments supporting public health research and biomedical innovation. Their engagements reflect a pattern of direct procurement of specialized equipment rather than broad service contracts, indicating trusted vendor status for high-sensitivity, mission-aligned hardware. The company’s primary industry focus is analytical laboratory instrument manufacturing (NAICS 334516), with secondary capabilities in computer systems design services (NAICS 541512) to support instrument control, data acquisition, and system integration. This dual focus enables them to deliver fully integrated genomic research systems rather than standalone devices, distinguishing them in the life sciences instrumentation market. As a privately held entity based in Daly City, California, DNA SCRIPT INC operates without federal certifications but maintains a focused presence in the government biomedical and defense technology markets. Their geographic location supports proximity to leading biotech and defense R&D hubs on the West Coast, reinforcing their role as a specialized supplier to federal science and technology programs.